Metastable Pluripotent States in NOD-Mouse-Derived ESCs  by Hanna, Jacob et al.
Cell Stem Cell
Article
Metastable Pluripotent States
in NOD-Mouse-Derived ESCs
Jacob Hanna,1,4,* Styliani Markoulaki,1,4 Maisam Mitalipova,1 Albert W. Cheng,1,2 John P. Cassady,1,3 Judith Staerk,1
Bryce W. Carey,1,3 Christopher J. Lengner,1 Ruth Foreman,1,3 Jennifer Love,1 Qing Gao,1 Jongpil Kim,1
and Rudolf Jaenisch1,3,*
1The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
2Computational and Systems Biology Program
3Department of Biology
Massachusetts Institute of Technology, Cambridge, MA 02142, USA
4These authors contributed equally to this work
*Correspondence: hanna@wi.mit.edu (J.H.), jaenisch@wi.mit.edu (R.J.)
DOI 10.1016/j.stem.2009.04.015SUMMARY
Embryonic stem cells (ESCs) are isolated from the
inner cell mass (ICM) of blastocysts, whereas epiblast
stem cells (EpiSCs) are derived from the postimplan-
tation epiblast and display a restricted develop-
mental potential. Here we characterize pluripotent
states in the nonobese diabetic (NOD) mouse strain,
which prior to this study was considered ‘‘nonpermis-
sive’’ for ESC derivation. We find that NOD stem cells
can be stabilized by providing constitutive expres-
sion of Klf4 or c-Myc or small molecules that can
replace these factors during in vitro reprogramming.
The NOD ESCs and iPSCs appear to be ‘‘metastable,’’
as they acquire an alternative EpiSC-like identity after
removal of the exogenous factors, while their reintro-
duction converts the cells back to ICM-like pluripo-
tency. Our findings suggest that stem cells from
different genetic backgrounds can assume distinct
states of pluripotency in vitro, the stability of which
is regulated by endogenous genetic determinants
and can be modified by exogenous factors.
INTRODUCTION
Mouse embryonic stem cells (ESCs), isolated from the inner cell
mass (ICM) of blastocysts, can be propagated in vitro in an undif-
ferentiated state and recapitulate all defining features of ICM
cells (Jaenisch and Young, 2008). ICM-derived ESCs, when
used to generate chimeras, can contribute to all somatic cell line-
ages and to germ cells and maintain both X chromosome alleles
in a reactivated state but are unable to contribute to the trophec-
toderm lineages (Rossant, 2008). Mouse ESC-like cells derived
either by somatic cell nuclear transfer or by direct in vitro reprog-
ramming (termed induced pluripotent stem cells [iPSCs]) share
all of these defining features (Hanna et al., 2008; Takahashi
and Yamanaka, 2006; Wakayama et al., 1998; Wernig et al.,
2007).
Despite their apparent common origin from the ICM and their
ability to propagate in vitro while maintaining pluripotency,human ESCs are phenotypically and functionally distinct from
mouse ESCs (Thomson et al., 1998). Human ESCs require
different growth conditions and rely on bFGF and Activin A/
TGFb signaling to maintain their pluripotent state, whereas
mouse ESCs require leukemia-inhibiting factor (Lif)/Stat3 and
Bmp4 signaling (Xu et al., 2005; Ying et al., 2003). Human
ESCs differ epigenetically from mouse ESCs by several criteria
such as X chromosome inactivation and pluripotency factor
promoter occupancy across the genome (Boyer et al., 2005;
Silva et al., 2008b; Tesar et al., 2007). Recently, pluripotent cells
from the epiblast of postimplantation murine embryos termed
epiblast stem cells (EpiSCs) have been isolated and found to
recapitulate defining features of human stem cells (Brons et al.,
2007; Tesar et al., 2007). EpiSC and human ESCs share the flat-
tened morphology, intolerance to passaging as single cells,
dependence on Activin/Nodal signaling, inactivation of the
X chromosome in female cell lines, and the ability of some of
the isolated EpiSC lines to differentiate into trophectoderm. In
contrast to mouse ESCs, EpiSCs are extremely inefficient to
generate chimeras and are unable to contribute to the germline
(Brons et al., 2007; Guo et al., 2009; Tesar et al., 2007). The simi-
larities between human ESCs andmouse EpiSCs have provoked
questions concerning the nature, origin, and in vivo counterpart
of human ESCs during normal development (Lovell-Badge,
2007).
Recent advances provided by new genetic and chemical
approaches to isolate stem cells have enabled the derivation of
iPSCs and ICM- or epiblast-derived stem cells from different
species. For instance, while EpiSCs can be generated from
‘‘nonpermissive’’ species such as rat, ESCs cannot be estab-
lished from the rat ICM under the same conditions used to isolate
mouse ESCs (Brons et al., 2007). Moreover, whereas rat ICM-
derived ESCs or iPSCs generated via transduction of Oct4,
Sox2, Nanog, and Lin28 can only be propagated in the presence
of glycogen synthase kinase 3 (GSK3) and mitogen-activated
protein kinase pathway (ERK) inhibitors (2i conditions) (Li et al.,
2008, 2009; Buehr et al., 2008), rat iPSCs generated with consti-
tutively expressed lentiviruses encoding Oct4, Sox2, Klf4, and
c-Myc could be propagated like mESCs without these inhibitors
(Liao et al., 2009). Moreover, EpiSCs can be converted into ESCs
byoverexpressingKlf4 andgrowing the cells in 2i conditions (Guo
et al., 2009). These findings raise fundamental questions relatingCell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc. 513
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when deriving iPSCs from ‘‘permissive’’ and ‘‘nonpermissive’’
strains?What are themolecular determinants involved in defining
the epiblast- versus ICM-like stem cell states? Could such deter-
minants impinge on the ability of certain strains to adapt one
pluripotent state but not the other? Would alternative pluripotent
states be adapted if keymolecular determinants are stabilized or
neutralized?
To address these questions, we used the nonobese diabetic
(NOD) mouse strain as a model to characterize different isolated
pluripotent states, as this strain is nonpermissive for the deriva-
tion of ESCs, but allows the isolation of EpiSCs from day E6.5
embryos (Brons et al., 2007). We found that continuous ectopic
expression of Klf4 or c-Myc transcription factors is sufficient for
derivation of ICM-like pluripotent NOD iPSC and ESCs. Supple-
menting mouse ESC growth conditions with small molecules
known to replace the function of Klf4 and c-Myc during iPSC
generation can facilitate the derivation of germline-competent
NOD ESCs. Importantly, upon removal of the exogenous factors
that help maintain the ICM-like cell state, the NOD pluripotent
cells adapted an alternative epiblast-like pluripotent state and
were functionally and molecularly similar to EpiSCs. Our results
provide an example where failure to stabilize ICM-like pluripo-
tency from a nonpermissive strain can lead to the attainment of
an in vitro acquired alternative pluripotent state. Moreover, these
findings support the notion that appropriate growth conditions
may have not yet been devised to allow in vitro stabilization of
ICM-like pluripotent cells from other species than mouse and
rat, possibly including human.
RESULTS
Derivation of Transgene-Dependent iPSCs
from NOD Mice
We attempted to derive NOD iPSCs by infecting mouse embry-
onic fibroblasts (MEFs)with doxycycline (Dox)-inducible lentiviral
vectors encoding the four reprogramming factors Oct4, Sox2,
Klf4, and c-Myc (see Figure 1A for definitions) and a consti-
tutively active lentivirus encoding the reverse tetracycline trans-
activator (Ubi-M2rtTA) (Figure 1B). The infected NOD and control
129 MEFs were cultured in the presence of Dox, and colonies
appeared 12 days after Dox induction, many of which acquired
ESC-like morphology. However, unlike the 129-derived iPSCs
that could be maintained in the absence of Dox after 20–30
days, the NOD ESC-like cells differentiated upon Doxwithdrawal
(Figure 1B). To analyze individual iPSC-like clones, colonies were
picked from transduced NOD-MEF cultures at day 16 and further
passaged in thepresenceofDox for up to45days.AfterDoxwith-
drawal, all 120 Nanog+ NOD-iPSC colonies underwent differen-
tiation, while the majority of 129-derived iPSC lines remained
undifferentiated (Figure 1C). The Dox-dependent NOD-iPSC
clones had all the characteristics of pluripotent ESCs such as
expression of ESC markers, demethylation of the endogenous
Oct4 andNanog promoters, and reactivation of endogenous plu-
ripotency genes (Figures 1D–1F). Finally, the Dox-dependent
NOD-iPSCs generated differentiated teratomas and adult
chimeras (Figures 1G and 1H). These results suggest that the
four factors are capable of inducing a pluripotent ESC-like state
in NOD somatic cells. However, in contrast to iPSCs from the514 Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc.129 strain, the NOD pluripotent state was unstable, requiring
the continuous expression of the reprogramming factors.
Constitutive Ectopic Expression of Klf4 or c-Myc
Facilitates Derivation of NOD ESCs and iPSCs
To define the exogenous factors required to stabilize pluripo-
tency in the NOD background, Dox-dependent iPSCs were
transduced with constitutively expressed lentiviruses encoding
reprogramming factors, and the ability of the cells to propagate
was tested after Doxwithdrawal (Figure 2A). Constitutive expres-
sion of Klf4 or c-Myc, but not Oct4 or Sox2, enabled the deriva-
tion of Dox-independent NOD iPSC clones (Figure 2B). All
Dox-independent NOD iPSCs carried the Ubi-c-Myc or Ubi-Klf4
proviruses and expressed transgene-encoded transcripts
(Figures 2C and 2D). The NOD iPSCs stained positive for pluripo-
tency markers and generated teratomas (Figures 2E and 2F).
Factor transduction by retroviral vectors, which are silenced in
ESCs and iPSCs (Jahner et al., 1982), failed to yield any iPSCs
from NOD mice, consistent with the requirement for continuous
expression of c-Myc and Klf4 (Figure 2G). Conversely, iPSCs
were readily isolated from NOD fibroblasts by using a combina-
tion of retroviruses encoding OSM factors and a constitutive
virus expressing Klf4, or a combination of retroviruses encoding
OSK factors and a constitutively expressed lentivirus expressing
c-Myc (Figure 2G). When Dox-inducible lentiviruses encoding
c-Myc or Klf4 were used in the latter combinations instead of
the constitutively expressed lentiviruses, NOD iPSC lines could
only be grown in the presence of Dox (Figure 2G). The derivation
of iPSCs from rat fibroblasts required similar conditions
(Figure 2G).
We tested whether constitutive expression of c-Myc and/or
Klf4 would allow derivation of ESCs from NOD ICMs. NOD blas-
tocysts failed to yield any ESCs under conditions routinely used
for ESC derivation (Figure 3A). While NOD-ICM outgrowths were
obtained after plating on feeders, the cells did not survive
passaging (Figure 3B). However, when NOD ICM outgrowths
were infected with constitutive lentiviruses encoding Klf4 or
c-Myc, the cultures could be dissociated and maintained in
mouse ESC conditions (defined as mESM: DMEM supple-
mented with fetal bovine serum [FBS] and Lif grown on irradiated
feeders), resulting in the generation of independent NOD ESC
lines carrying either c-Myc or Klf4 proviruses (Figures 1A and
3C). Southern blot and RT-PCR analysis verified proviral integra-
tion and transgene-specific transcripts in the isolated lines
(Figures 3D and 3E). The NOD-ESC lines had a normal karyotype
and a cell-cycle pattern identical to control V6.5 ESC, expressed
pluripotency markers, and generated adult chimeras with germ-
line contribution (Figures 3F–3I and Table S1 available online).
Tumor formation was observed in some of the c-Myc transgenic
NOD ESC line derived chimeras and offspring (data not shown),
probably as a result of the ectopic expression of the c-Myc onco-
genic transgene (Okita et al., 2007).
Generation of Genetically Unmodified Germline-
Competent NOD ESCs
Small molecules have been identified to replace some of the re-
programming factors in iPSC derivation (Huangfu et al., 2008; Shi
et al., 2008). We have found that Wnt signaling promotes the
derivation of iPSCs in the absence of c-Myc (Marson et al.,
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Figure 1. Generation of Transgene-Dependent NOD iPSCs
(A) Definitions and terms of reagents and cells used in this study.
(B) Strategy used for reprogramming NOD or 129MEFs into iPSCs by infection with Dox-inducible lentiviruses (TetO) encoding O, S, K,M. Representative images
of colonies observed at different stages in the as indicated in the panels (P, passage number).
(C)Coloniesoriginally isolatedatday16after infection fromthree independentexperiments fromNODand129MEFcultures;onlycolonies thatstainedpositive forNanog
at day 45while beingmaintainedwith Doxwere analyzed. Right column lists the number of iPSC lines that remainedpluripotent (Nanog andOct4 positive)withoutDox.
(D) Immunostaining for pluripotency markers of NOD iPSC subclone #1 maintained on Dox. AP, alkaline phosphatase.
(E)Methylation analysis ofOct4 andNanog promoters.Open squares indicate unmethylatedandfilled squaresmethylatedCpGdinucleotides.Shownare six represen-
tative sequenced clones from NODMEFs, V6.5 ESCs, and two different Dox-dependent NOD iPSC lines.
(F)QuantitativeRT-PCRanalysisspecific for the reactivationof theendogenous indicatedpluripotency-relatedgenes inDox-dependentNOD iPSC lines.V6.5ESCs,
iPSCs grown in the absence of Dox, andMEFs are used as controls. Relative expression levels were normalized to the average expression of control ESC line V6.5.
(G) Teratoma derived from Dox-dependent NOD-iPSC#6 cell line.
(H) Chimeric mice derived from Dox-dependent NOD-iPSCs. Chimerism is indicated by the albino and brown coat colors.Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc. 515
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Background Is Stabilized by Constitutive
Ectopic Expression of Klf4 or c-Myc
(A) Experimental plan for deriving Dox-indepen-
dent NOD iPSC lines. Constitutive lentiviruses
driven by the ubiquitin promoter (abbreviated as
Ubi) encoding different transcription factors were
used to transduce Dox-dependent NOD iPSCs fol-
lowed by Dox withdrawal.
(B) Images of cultures depicting colony growth in
the absence of Dox after infection of NOD iPSCs
with constitutive lentiviruses encoding the indi-
cated factors.
(C) RT-PCR for detection of transgene specific
expression of O, S, K, M in NOD-iPSC#1 cells in-
fected with c-Myc (M) or Klf4 (K) constitutive lenti-
virus that were maintained independent of Dox.
V6.5 ESCs and parental uninfected pluripotent
(on Dox) or differentiated (40 hr after Dox with-
drawal) NOD iPSCs in the presence or absence
of Dox were used as controls.
(D) PCR analysis for the detection of Ubi-c-Myc
and Ubi-Klf4 proviruses in genomic DNA of subcl-
oned infected NOD iPSC lines.
(E) Immunostaining for pluripotency markers of
Dox-independent NOD iPSC lines that had been
infected with Ubi-Klf4 or Ubi-c-Myc lentiviruses.
(F) Teratomas derived from NOD iPSC#1 infected
subclones.
(G) Summary of infections performed on mouse
NOD and 129Sv/Jae MEFs and Rat TTFs with
reprogramming factors transduced either byMolo-
ney retroviral backbone vectors (pLib), by constitu-
tively expressed lentiviral vectors (Ubi), or by Dox-
inducible lentiviral vectors (TetO). Experiments
using the three different infection protocols were
performed side by side. The ability to derive iPSCs
was defined by the detection of Nanog-positive
clones that were developmentally pluripotent as
tested by teratoma formation (129 and NOD cell
lines) or EB formation (Rat iPSC lines) and is indi-
cated by ‘‘+.’’ NA, not applicable.2008) and have identified Kenpaullone (KP), a GSK3b and CDK1/
cyclin B inhibitor, as a small molecule that replaces Klf4 during
iPSC reprogramming (Lyssiotis et al., 2009). We tested whether
these compounds could replace constitutive Klf4 or c-Myc
expression in propagating NOD iPSC and ESCs. Dox-dependent
NOD-iPSCs were grown in mESM lacking Dox but supple-
mented with (1) Wnt3a, (2) the glycogen synthase kinase 3 inhib-
itor CHIR99021 (CH), or (3) KP. All three conditions supported
Dox-independent growth of pluripotent NOD-iPSCs (Figures
4A and S1). Notably, it was recently reported that the ‘‘2i’’ culture
conditions, using the ERK-cascade inhibitor PD184352 (PD) and
the GSK3 inhibitor CH or 6-bromo-indirubin-30-oxime (BIO),
facilitate the derivation of rat ESCs (Buehr et al., 2008; Li et al.,
2008). Consistent with this observation, NOD iPSCs were readily
propagated independently of Dox in the presence of 2i, although
at reduced single-cell cloning efficiency compared to mESM
conditions supplemented with both KP and CH (KP/CH)
(Figure 4B). In a similar manner to KP, the combination of PD/
CH replaced the requirement for ectopic expression of the Klf4
transgene during iPSC generation (Figure S2). Rat iPSCs could516 Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc.also be generated and propagated in mESM with KP/CH
(Figure S3). Importantly, KP/CH did not inhibit ERK phosphoryla-
tion, suggesting that stabilization of pluripotency can occur in the
absence of ERK inhibition (Figure S4).
To derive NOD ESCs, E3.5 NOD blastocysts were plated on
mouse feeders and grown under the optimized culture condi-
tions supplemented with the different inhibitors (Figure 4C). We
isolated 16 lines in mESM containing KP (NOD-ES#85), KP/CH
(NOD-ES#43), or PD/CH (NOD-ES#75). The ESCs remained
stable in culture but required the continuous presence of the
defined inhibitors, expressed pluripotencymarkers, and retained
a normal karyotype (Figures 4D, 4E, and S5). The cells generated
adult chimeras (Figure 4F) and contributed to the germline
(Figure 4F and Table S1). Importantly, the NOD ESCs or iPSCs
maintained with exogenous factors expressed endogenous
levels of Klf4 and c-Myc similar to those observed in control
129 ESCs (Figure 4G). This argues that the inability of NOD cells
to stabilize pluripotency in the absence of the exogenous factors
is not due to failure to reactivate the endogenous Klf4 or c-Myc
genes. Finally, we tested whether NOD ESCs could be targeted
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porated with a linearized Nanog-GFP knockin targeting
construct (Hatano et al., 2005), followed by puromycin selection.
Resistant colonies were picked after 10 days of drug selection,
and 2 out of 16 colonies analyzed demonstrated correct target-
ing of the Nanog locus (Figure 4H).
Destabilized NOD ICM-like Stem Cells Adapt an
Alternative Epiblast-like Pluripotent State
TheNOD stem cells were stabilized by ectopic expression of Klf4
or c-Myc or the presence of small molecules and displayed ICM-
like pluripotency, as evidenced by their ability to generate
chimeras with germline contribution. Upon plating these cells
after withdrawal of the exogenous stimuli (Dox or inhibitors),
we noticed distinct colonies with flat morphology (0.3% of
plated cells) (Figure 5A). These colonies could not be propagated
following dissociation into single cells (by trypsinization), typi-
cally used to passage mouse ESCs, but could be stably propa-
gated by passage of smaller clumps using collagenase or
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Transgenic NOD ESC Lines
(A) Summary of ESC derivation efficiency from
NOD and permissive strain control blastocysts.
(B) Representative images for NOD blastocyst at
embryonic day 3.5 and ICM outgrowths after
plating the blastocysts on feeder cells. The cells
were infected with the indicated viruses and
passaged in mESM.
(C) Representative images of NOD colonies after
infection with c-Myc and Klf4 viruses at passage
two (P2) and stable established NOD ESC lines
at P5. NOD ESC 1M was derived after infections
with Ubi-c-Myc, and three lines were obtained
following Ubi-Klf4 infection (NOD ESC 2K is
shown).
(D) Transgene expression by RT-PCR in various
NOD ESC lines. MEFs infected with O, S, K, M
viruses were used as positive controls.
(E) Southern analysis of c-Myc and Klf4 viral inte-
grations in representative NOD ESC lines derived
following viral infection. NOD MEFs are used as
background controls.
(F and G) Karyotype and cell-cycle analysis of
transgenic NOD ESC lines.
(H) Immunofluorescent staining of NOD ESC lines
for pluripotency markers.
(I) NOD ESC-derived chimeras from NOD ESC 1M
and 2K cell lines were mated with NOD mice with
albino offspring indicating germline transmission.
manual dissociation in the presence of
bFGF (DMEM/F12 supplemented with
FBS and bFGF, referred to as epiESM).
The flat colonies were morphologically
distinct from mouse ESCs and had
a similar morphology to EpiSC cells and
were termedEpiSC-like iPSCs (Figure1A).
Moreover, the NOD EpiSC-like iPSC line
#1 and the Dox-dependent NOD-iPSC
#1 cells from which the former line was
derived carried an identical Sox2 genetic
integration pattern, thus excluding contamination as a source
for the EpiSC-like cells (Figure 5B).
NODEpiSCs have been previously derived from the epiblast of
day E6.5 developing embryos (Brons et al., 2007). This prompted
us to test whether EpiSC-like cells can also be isolated fromNOD
ICM in the absence of exogenous factors. NOD day E3.5
blastocysts were explanted, and ICM outgrowths were manually
dissociated after plating in epiESM derivation medium (see the
Experimental Procedures) and propagated in epiESM, resulting
in stable lines termed EpiSC-like ESCs (Figures 1A, 5C, and
S6). NOD EpiSC-like iPSC and NOD EpiSC-like ESC lines (see
Figure 1A) derived by the different approaches expressed pluri-
potency markers, were not capable of generating chimeric mice
but were pluripotent, as evidenced by their ability to generate
teratomas (Figures 5D and 5E and Table S1) (Brons et al.,
2007; Guo et al., 2009; Tesar et al., 2007). In contrast, when
the same derivation protocol was used on 129 embryos, typical
murine ESCs were generated that could be passaged by
trypsinization, were dependent on Lif/Stat3 signaling for theirCell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc. 517
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Figure 4. Generation of Genetically Unmod-
ified Germline-Competent NOD ESCs
(A) Experimental outline for derivation of iPSC lines
that grow in the presence of small molecules and in
the absence of Dox. Representative images of
NOD iPSC lines growing in mESM supplemented
with the indicated small molecules or growth
factors.
(B) Single-cell cloning efficiency of NOD iPSCs in
different growth conditions. WT or NOD-iPSCs
grown in mESM and KP were sorted in 96-well
plates and cultured in mESM supplemented with
small molecules. The number of wells containing
Nanog+ colonies was counted after 6 days. Effi-
ciencies were normalized to that of C57B6/
129F1-iPSCs (‘‘permissive’’ controls) plated in
mESM and defined as 100%. SD for average effi-
ciencies from two experiments are shown.
Student’s t test p value compares KP/CH to PD/
CH mESM conditions for NOD iPSCs.
(C) Expansion of day E3.5 ICM-derived NOD ESCs
in the presence of KP, KP/CH, or PD/CH and deri-
vation of stable ESC lines. Images of initial colonies
observed at passage 2 after embryo dissociation
are shown together with representative images at
later passages.
(D) Karyotype of NOD ESC lines.
(E) Immunostaining of NOD ESC lines for pluripo-
tency markers. Inhibitors used during cell line deri-
vation and propagation are indicated.
(F) Chimerism in adult mice generated from the
indicated cell lines is evident by the presence of
agouti (brown) and albino coat color originating
from the NOD background. Lower panel demon-
strates germline transmission obtained from
a male NOD ESC #43-derived chimera that was
mated to an NOD female.
(G) Real-time PCR analysis for endogenous ex-
pressed Oct4, c-Myc, and Klf4 genes in NOD
iPSC and ESCs grown in the indicated conditions.
Relative expression levels are normalized to levels
detected in control V6.5 ESCs.
(H) Southern analysis indicating correct targeting
of the endogenous Nanog locus in NOD ESCs
with Nanog-GFP knockin targeting construct.self-renewal, and were capable of generating adult chimeras
with germline transmission (Figure S7 and Table S2).
We characterized NOD-derived ESC and EpiSC-like cells in
a series of assays. (1) Cells were transfected with a luciferase
reporter construct under the control of either the distal or the
proximal enhancers that control expression of the Oct4 gene in
the mouse ICM and epiblast, respectively (Tesar et al., 2007).
The NOD EpiSC-like ESC and iPSC lines preferentially utilized
the Oct4 proximal enhancer similar to EpiSCs (Figure 5F). In
contrast, NOD ESCs and iPSCs grown in mESM with KP/CH, as
well ascontrols including129mESCsor iPSCsderivedandgrown
in mESM or epiESM conditions, utilized the distal enhancer
consistent with the notion that these cells resemble mouse ESCs
(Tesar et al., 2007). (2) Lif-dependent self-renewal: mouse ESCs
are dependent on Lif signaling and readily differentiate when
exposed to JAK inhibitor (JAKi) that blocks Stat3 phosphoryla-
tion. In contrast, mouse EpiSCs or human ESCs rely on activin A
(Inhb)/Nodal signaling tomaintain pluripotency and rapidly differ-518 Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc.entiate in the presence of ALKi, an inhibitor of type I activin
receptor-like kinases (Tesar et al., 2007). We exposed ESCs
andEpiSCs to either ALKi or JAKi to test which of these pathways
controls their self-renewal. NOD ICM-derivedESCsmaintained in
mESM KP/CH conditions were dependent on Lif/Stat3 signaling
in contrast to NOD EpiSC-like cells, which required Activin A/
Nodal signaling (Figure 5G). (3) Gene expression: EpiSCs and
ESCs display different developmental potentials and several
key pluripotency genes are differentially expressed in the two
cell types (Tesar et al., 2007). Unbiased clustering of global
gene expression profiles demonstrated that the NOD EpiSC-
like ESC and iPSC lines clustered closely with EpiSCs, and
were distinct from 129 ICM-derived ESCs grown inmESMor epi-
ESM conditions (Figures 5H and S9). Our results support the
notion that, in spite of the presence of Lif and other growth factors
present in the serum or provided by the feeders, NOD stem cells
in vitro adapt a pluripotent state that highly resembles EpiSCs
when the exogenous components that maintain their ICM-like
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Figure 5. Generation of NOD EpiSC-like
ESC and iPSCs
(A) Dox-dependent NOD-iPSC lines were trypsi-
nized and plated on MEF feeders and grown in
mESMwithout Dox. Representative image of colo-
nies typically observed 5–8 days after plating that
can be manually passaged using collagenase
and stably propagated in epiESM conditions.
(B) Southern blot analysis indicating identical inte-
gration pattern for Sox2 transgene in NOD-iPSC #1
and its derived cell line NOD EpiSC-like iPSC #1.
Black triangle indicates endogenous band; white
triangle indicates transgenic band.
(C) Derivation of epiblast-like ESCs fromNODblas-
tocysts by plating the embryos in EpiSC derivation
medium and passaging ICM outgrowths after 5–8
days in epiESM conditions. Continued culture in
epiESM and manual dissociation supported the
growth of colonies with flat morphology-like colo-
nies.
(D) Immunofluorescent staining for pluripotency
markers in EpiSC, EpiSC-like NOD iPSC, and
ESC lines.
(E) Teratoma formation of NOD epiblast-like ESC
and iPSC lines.
(F) Evaluation of Oct4 distal enhancer (DE) and
proximal enhancer (PE) reporter gene activity in
the indicated pluripotent lines. Baseline activity
was analyzed by infecting with an empty vector.
(G)Cell sampleswere equally divided andplated on
feeders in the indicated growth medium, and 24 hr
later the wells were supplemented with either JAKi
or ALKi or were kept without any inhibitor. At day 6
the wells were stained for Oct4 to determine the
relative percentage of pluripotent colonies. Values
indicated are normalized to internal control sample
(growth medium without inhibitors: gray bars) in
which each cell line was not exposed to inhibitors
and defined as 100%. Relative percentage lower
than 30% was defined as ‘‘sensitivity’’ to the pres-
ence of the inhibitor.
(H) Whole genome cluster analysis of transcripts
from pluripotent cell lines analyzed. Top 5000
differentially expressed probes were selected by
cross-array standard deviations of the normalized
expression values and included in unbiased cluster
analysis. Growth conditions and passage number
for the cell lines are indicated.pluripotent state are removed. In contrast, 129 ESCs maintained
their ICM-like pluripotency in epiESM conditions and were
dependent on Lif/Stat3 pathway stimulated by signals originating
from the FBS and feeders used in these growth conditions.
Consistent with this, differentiating 129 ESCs into EpiSC-like
statewasachievedonly upon removal of FBSandLif and required
prolonged culturing of the cells in serum-free N2B27 defined
medium supplemented with high levels of bFGF and Activin A
(data not shown, Figure S7, and Guo et al. [2009]).
Pluripotent States of NOD Stem Cells Are Unstable
and Are Affected by Exogenous Factors
We asked whether the exogenous stimuli defined in this study
could interconvert the two distinct pluripotent states. We first
testedwhether infectionof previously characterizedE5.5-derived
129EpiSCs (Tesar et al., 2007)with a Klf4 or c-MycDox-induciblevector could convert the EpiSCs to an ICM-like pluripotent state.
Consistent with other reports, EpiSCs did not spontaneously
convert into ESC-like cells upon culturing in mESM, but rather
differentiated (Guo et al., 2009; Tesar et al., 2007). InfectedEpiSC
cultures maintained in mESM with Dox gave rise to distinguish-
able, small, round colonies (Figure 6A). When trypsinized into
single cells and propagated on MEFs, they eventually acquired
typical mouse ESC-like morphology. Dox was withdrawn after
7–12 days, and clonal lines termed Epi-iPSCs (Figure 1A and
Guo et al. [2009]) were stable and morphologically indistinguish-
able frommouse ESCs (Figure 6A). Southern analysis verified the
presence of c-Myc or Klf4 proviral integrations (Figure S10).
Moreover, unlike their donor EpiSCs, Epi-iPSCs grew stably in
mESMconditions, and their pluripotencywasdisruptedby inhibi-
tion of Stat3, but not of Activin/Nodal pathway (Figure 6B). Epi-
iPSCs showed preferential utilization of the Oct4 distal enhancerCell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc. 519
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Figure 6. Resetting the Identity of Pluripotent States
(A) 129 EpiSC cells derived from the epiblast of day E5.5 mouse embryos were reprogrammed into ICM-like cells after infection with TetO-Klf4 or c-Myc lenti-
viruses and culture in the mESM + Dox. Images on the bottom show representative colony formation observed 4–6 days after infection, which were passaged on
MEF feeders. The cell lines were termed Epi-iPSCs.
(B–C) Evaluation of Oct4 enhancer activity and sensitivity to JAKi and ALKi on the converted cell lines was performed as indicated in (Figures 5F and 5G).
(D) Chimeric mice generated from the indicated Epi-iPSCs lines as evidenced by the agouti coat color.
(E) Efficiencies of iPSC derivation from EpiSC and somatic cells: 129 EpiSCs were infected with Teto-Klf4-2A-mOrange or Teto-cMyc-2A-mOrange lentiviruses,
and after 3 days of Dox inductionmOrange+ infected cells were single cell sorted in 96-well plates. Different hematopoietic cells from transgenic reprogrammable
mice carrying identical integration pattern of the Dox-inducible OSKM transgenes were single cell sorted in 96-well plates. HSC, hematopoietic stem cell enriched
fraction; CMP, common myeloid progenitors. Efficiency for Nanog+ cells stable in mESM was determined at day 25 for all samples. Average results from two
independent experiments are shown. *p value < 0.05 for the outlined efficiency comparisons.
(F) Converting NOD EpiSC-like ESCs into transgene-dependent ICM-like cells. EpiSC-like cells were generated from NOD-ESC line #43 after withdrawal of KP/
CH and growing the cells in epiESM. As in (A), the line was infectedwith TetO-K, andwithin two passages inmESM in the presence of Dox, stable lines termedEpi-
iPSC were derived. The lower pictures indicate that the cell line required Dox or the presence of KP/CH to remain stable in culture. Factors and growth conditions
utilized to facilitate the identity conversion at each step are indicated. The pluripotency statewas evaluated and defined based onOct4 enhancer activity and ALKi
or JAKi sensitivity (indicated in blue or red).520 Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc.
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Metastability of Pluripotent Statessimilarly to mESCs (Figure 6C). Epi-iPSCs were transcriptionally
indistinguishable from 129 ICM-like ESCs and did not cluster
with the EpiSCs (Figures 5H and S9). High-contribution chimeras
with germline contributionwere derived fromEpi-iPSCs, verifying
that ICM-like pluripotency had been re-established (Figure 6D
and Table S1). A recent report (Guo et al., 2009) showed that
Klf4 overexpression as well as growth in PD/CH was required to
convert EpiSCs into iPSCs. In contrast, we found that such
conversion can be accomplished either by overexpression of
the Klf4 or the c-Myc transcription factor or by supplementing
the medium with KP or KP/CH or PD/CH, consistent with the
ability of these small molecules to replace Klf4 or c-Myc during
iPSC generation (Figures 6A–6D, S2, S10, and S11). It should
be emphasized that only a small fraction of Klf4 or c-Myc
transduced EpiSC cells (up to 2%) can be reprogrammed back
to ICM-like pluripotency (Figure 6E and Guo et al. [2009]).
However, the efficiency of converting EpiSCs into iPSCs was
within the same range as reprogramming efficiencies observed
ofhematopoieticcells at variousdifferentiationstages (Figure6E).
Collectively, these findings indicate that expression of OSKM
transcription factors can induce ICM-like pluripotency in different
somatic cells and that the efficiency of reprogramming is not
dictated by the differentiation state of the donor cell but rather
depends on additional parameters such as cytokine stimulation,
cell-cycle rate, and enhancement by additional reprogramming
factors (e.g., C/EBPa for mature B cells reprogramming effi-
ciency) (Figure 6E and Hanna et al. [2008]).
Finally, we tested whether similar manipulations could convert
the identity of NOD EpiSC-like cells to that of the ICM-like plurip-
otent state. We derived NOD EpiSC-like ESCs from germline-
competent NOD-ES#43 by withdrawing KP/CH and growing
the cells in epiESM for over eight passages (Figure 6F). Subse-
quently, the cells were infected with TetO Klf4 and grown in
mESM and Dox. This treatment readily converted the EpiSC-
like into ICM-like cells. However, the ICM-like pluripotent state
on the NOD background remained stable only in the presence
of Dox inducing the Klf4 transgene or, alternatively, by supple-
menting mESM with KP/CH (Figure 6F). Identical results were
obtainedwhenKP/CHor PD/CH instead of Klf4 and c-Myc trans-
genes were used to reprogram NOD and 129 EpiSC cells to ICM
like pluripotency (Figure S11). In summary, expression of Klf4 or
c-Myc converts the EpiSC-like state to ICM-like pluripotency.
However, unlike 129 Epi-iPSC lines, continuous presence of the
same exogenous factors is required to stabilize the NOD Epi-
iPSCs and to prevent reversion into the EpiSC-like state.
DISCUSSION
Stem cells characterized by different states of pluripotency and
developmental potential have been derived under defined
growth conditions. For example, growth of explanted mouse
epiblasts in conditions containing bFGF and Activin, which are
routinely used to isolate human ESCs, generates EpiSC cells
that have a restricted ability to contribute to chimericmice (Brons
et al., 2007; Tesar et al., 2007; Thomson et al., 1998). In contrast,
‘‘mouse ESC conditions’’ stabilize a pluripotent ICM-like state
with the potential to generate high-contribution chimeras in
‘‘permissive’’ mouse strains such as 129 (Ying et al., 2003). We
found that identical culture conditions failed to induce ICM-likeESCs in the ‘‘nonpermissive’’ NOD-derived ICM explants. Stable
transduction of the NOD ICMexplants with c-Myc or Klf4 or addi-
tion of small molecules to the medium that replace the action of
these factors during iPSC derivation was sufficient to generate
NOD ESCs that were indistinguishable from 129 ICM-derived
ESCs. The same stimuli were required to stabilize NOD fibro-
blast-derived iPSCs, supporting the notion that in vitro stability
of pluripotent state is dependent on genetic background rather
than on the method used to derive the stem cells. However,
the pluripotent state of NOD-ESCs was unstable despite the
presence of Lif and could bemaintained only through continuous
expression of Klf4 or c-Myc or in the presence of inhibitors.
Silencing of the transcription factors or removal of the inhibitors
readily converted the cells to the EpiSC-like state. These cells
resembled previously defined EpiSCs by multiple criteria
including cellular morphology, signaling requirements, and gene
expression profiles (Tesar et al., 2007). We hypothesize that the
NOD genome lacks or carries genetic determinants that cause
instability of the ICM-like ESC state in vitro unless supported by
exogenous factors. It is also important to emphasize that our find-
ings relate to differences in stem cells of different genetic back-
ground grown in culture rather than reflecting in vivo differences,
as NOD embryos develop normally. Our defined conditions,
either with inhibitors or overexpressing transcription factors,
enable maintaining fully pluripotent NOD stem cells in vitro, and
upon injection of the cells into host blastocysts, the in vivo envi-
ronment probably substitutes for the requirement of exogenous
factors and allows the cells to contribute to chimera formation.
Metastable States of Pluripotency
The term ‘‘metastability’’ has been previously used to describe
transient changes within ICM-like ESC populations resulting
from oscillations in Nanog or Stella gene expression (Chambers
et al., 2007; Hayashi et al., 2008). Here, we apply this term to
describe the interconversion between two distinct pluripotent
states in NOD and 129 mouse strains. Our results suggest that
the ICM and EpiSC pluripotent states may be in a ‘‘metastable’’
equilibrium dictated by the genetic background where exoge-
nous factors can convert one state into another. Thus, one may
consider the two states of pluripotency, the ICM/ESC-like state
and the epiblast/EpiSC-like state, as two different levels of pluri-
potency (Figure 7). Exogenous factors such as c-Myc and Klf4 in
combination with Oct4 and Sox2 can induce the ICM-ESC-like
state from somatic cells. However, the stability of the ESC state
is determined by the genetic background: while ICM-ESCs or
iPSCs derived from a ‘‘permissive’’ genetic background such
as 129 or C57BL/6 are stable once established in the presence
of Lif, the ESC-like state of iPSCs or of ICM-derived pluripotent
cells of the ‘‘nonpermissive’’ NOD background remains unstable
with the maintenance of the pluripotent state depending on the
continuous expression of the exogenous factors in addition to
Lif/Stat3 signaling. Inactivation of the transcription factors or
removal of the inhibitors causes the ESC-like NOD cells to
assume an EpiSC-like state, characterized by reduced pluripo-
tency. Interconversion between these states can be controlled
by the absence or presence of the same factors (Figure 7).
Several lines of evidence support the notion that the conver-
sions between the different pluripotency states are due to cells
being inefficiently induced to successfully convert from one stateCell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc. 521
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Metastability of Pluripotent StatesFigure 7. Pluripotent States Are ‘‘Metastable’’
Model summarizing the requirements for in vitro stabilization of different pluripotent states in 129 (left half) and NOD (right half) mouse strains. ‘‘Metastability’’
pertains to describing a system with two or more equilibrium states (indicated by the stippled gray horizontal lines) that can interconvert by defined signals.
The ICM-like state is characterized by a greater developmental potential than the EpiSC-like state. The factors required for stabilizing the respective pluripotent
states in the different genetic backgrounds are indicated in green on the plateau lines for each state. The ICM-like pluripotent state in permissive 129 cells,
whether achieved by direct in vitro reprogramming or by ICM explantation, is stabilized by Lif/Stat3 signaling, while the bFGF/Activin/Nodal signaling stabilizes
the EpiSC-like state. Defined transcription factor or small molecules convert the EpiSC-like cells to the ICM-like ESC state (highlighted in orange on the left). The
129 andNODEpiSC-states are indistinguishable in their stability and growth condition requirements and can be reverted into ICM-like pluripotency by expression
of Klf4 or c-Myc or by specific inhibitors added to themedium. However, the ICM-ESC-like state is unstable on the NOD genetic background and requires contin-
uous expression of exogenous factors in addition to Lif (dashed black and red arrows).to another, rather than due to selection for rare pre-existing cells
constantly present in heterogeneous stem cell populations. First,
evidence for direct reprogramming of EpiSCs into iPSCs is sup-
ported by the observations that EpiSC cells do not convert spon-
taneously into ESC-like cells and that all derived Epi-iPSC lines
carried integrated viral transgenes (Figure S10 and Guo et al.,
[2009]). Second, the EpiSC to ESC conversion requires multiple
passages in defined media and continuous transgene induction,
which is similar to generating iPSCs from somatic cells (Figure 6;
Jaenisch and Young, 2008). Third, it is unlikely that NOD ESC
cultures carry already rare EpiSC-like cells, since the NOD iPSC
or ESC lines were passaged routinely by trypsinization, which
does not allow propagation of the EpiSC cells. Finally, the NOD
EpiSC-like iPSC line carried an identical Sox2 integration as its
parental Dox-dependent NOD iPSC line, indicating a clonal rela-
tion (Figure 5B). An important question remains why only a small
fraction of theNODESCs convert into an EpiSC state. One possi-
bility is that, after removal of the exogenous stimuli, the EpiSC
state becomes one of several epigenetic states that can be
acquired by the NOD ESCs upon differentiation.
Pluripotency in NOD Strain as a Paradigm for Other
‘‘Nonpermissive’’ Species?
It has been established that human and rhesus macaque ESCs
resemble the EpiSC rather than the ICM pluripotent state of
mouse cells, suggesting that ICM-like pluripotent cells might
have not been isolated from several species (Brons et al.,
2007; Byrne et al., 2007; Lovell-Badge, 2007; Tesar et al.,
2007; Thomson et al., 1998). When cultured under standard
ESC growth conditions, the pluripotent state of NOD stem cells
isolated from explanted blastocysts or from somatic cells by522 Cell Stem Cell 4, 513–524, June 5, 2009 ª2009 Elsevier Inc.in vitro reprogramming was the EpiSC-like state. The ICM-
ESC-like state in NOD cells could only be stabilized when exog-
enous factors such as Klf4 or c-Myc were added. Thus, it is
possible that ‘‘nonpermissive’’ species such as human, which
have yielded only EpiSC-like pluripotent cells, require specific
exogenous factors to maintain the ICM-like pluripotent state.
Consistent with this notion is that ICM-like iPSCs could be
generated from rat fibroblasts under identical culture conditions
to those used for the isolation of NOD iPSCs. This raises the
question whether the conditions that were successful for the
isolation of NOD ICM-like ESCs could be used to maintain
ICM-like ESCs from other ‘‘nonpermissive’’ species. It will also
be of great interest to define the genetic determinants that affect
the in vitro stability of pluripotent states from different genetic
backgrounds. Moreover, uncovering how Klf4, c-Myc, Wnt,
and MAPK pathways might converge and crosstalk in the re-
programming process, and whether they play a similar role in
fibroblast to iPSC and EpiSC to iPSC conversion, is a funda-
mental question relevant to understanding the mechanisms of
reprogramming (Markoulaki et al., 2009; Marson et al., 2008;
Silva et al., 2008a; Ying et al., 2008).
Generation of Germline-Competent NOD ESCs
The inability to derive germline-competent embryonic stem cells
on the NOD background has posed limitations in generating
genetically engineered NOD mice (Bach and Mathis, 1997). The
NOD strain has been instrumental for the studying of disease
progression and pathology of insulin-dependent diabetes melli-
tus (IDDM). NODmice spontaneously develop a form of diabetes
that closely resembles human IDDMasa result of an autoimmune
process directed against the pancreatic b cells. IDDM is a
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Metastability of Pluripotent Statespolygenic diseasewithmultiple parameters influencing suscepti-
bility disease progression. Until now, the only available approach
togenerate anNODknockout involves crossingofNODmicewith
a non-NOD strain carrying the desired allele and subsequently
backcrossing to NOD mice for at least 15 generations to ensure
re-establishment of the original NOD inbred genetic background
harboring all IDDM susceptibility loci. Thus, the generation of
germline-competent NOD ESCs circumvents an obstacle posed
on modeling IDDM in mice and would establish an efficient plat-
form for achieving direct gene targeting on the NODbackground.
EXPERIMENTAL PROCEDURES
Cell Culture and Viral Infections
mESM conditions refer to culturing the cells on irradiated MEFs in DME con-
taining 15% FCS, Lif, 1 mM glutamine (Invitrogen), 1% nonessential amino
acids (Invitrogen), and 0.1 mM b-mercaptoethanol (Sigma). These cells
(ICM-like) were passaged every third day as a single-cell suspension using
0.25% trypsin/EDTA. EpiSC and EpiSC-like cells were maintained in epiESM
conditions, which include maintaining the cells on mitomycin C inactivated
MEF feeder layers in epiESM (DMEM/F12 [Invitrogen] supplemented with
15% FBS [Hyclone], 5% knockout replacement serum [KSR; Invitrogen],
1 mM glutamine, 1% nonessential amino acids, and 4 ng/ml human FGF2
[bFGF] [R&D systems]). Cultures were passaged every 5–7 days either manu-
ally or enzymatically with collagenase type IV (Invitrogen; 1.5 mg/ml). The
density of feeder cells was crucial to maintaining the EpiSC- and EpiSC-like
cells in an undifferentiated state (density of 4 3 104 cells per cm2). Lentiviral
preparation and infection with doxycycline-inducible lentiviruses encoding
Oct4, Klf4, c-Myc, and Sox2 cDNA driven by the TetO/CMV promoter or
constitutive lentiviruses driven by ubiquitin promoter were done as previously
described (Hanna et al., 2007, 2008).
Small-Molecule Compounds
The following inhibitors were used at the indicated final concentrations: ALK
inhibitor (ALKi SB431542, Stemgent Technologies; 20 mM), JAK inhibitor I (Cal-
biochem 420099; 0.6 mM), KP (Sigma; 5 mM), PD (Pfizer; 0.8 mM), and
CHIR99021 (Stemgent; 3 mM).
Animals and ESC Derivation
NOD/ShiLtJ were obtained from the Jackson laboratory and bred in specific-
pathogen-free animal facility. Control MEFs were made from 129SvJae mice.
Non-NOD ESC lines derived used in this study as controls were derived from
matings between 129SvJae or B6D2F1mice. To derive ESC lines, ICM explants
were derived from day 3.5 blastocysts following procedures previously
described (Markoulaki et al., 2008). Where applicable, ESC derivation medium
was also supplemented with the indicated compounds (Table S2). Dissocia-
tion of the outgrowths by treatment with Trypsin was performed on day 5 after
plating, and the cells were further cultured in mESC derivation medium until
colonies appeared (typically after 5–7 days). From then on, established ESC
lines were cultured in mESM condition supplemented with the indicated
compounds. NOD EpiSC-like ESC lines were derived by similarly plating
blastocysts in EpiSC-derivation medium (for 100 ml, we added 15 ml FBS [Hy-
clone], 5 ml KSR, 5 ml Lif [1 3 107 U ESGRO/ml; Chemicon], Mek1 inhibitor
[PD98059; Cell Signaling Technology], hFGF2 [12 g/ml], 1 ml nonessential
amino acids, 1 ml glutamine solution, and 1ml pen/strep solution into
DMEM/F12). ICM outgrowths were manually passaged after 5–7 days and
were stably maintained in epiESM conditions. The 129 EpiSC cell line used
was previously described (Tesar et al., 2007) and was obtained from day
E5.5 129SvEv (Taconic) embryos and propagated in epiESM conditions.
Luciferase Reporter Assay
Constructs encoding the two previously characterized Oct4 enhancers (the
Oct3/4 DE- and Oct3/4 PE-SV40-Luc constructs) cloned into the pGL3-
Promoter Vector (Promega) were used to determine regulation pattern of
Oct4 expression (Tesar et al., 2007). Constructs were transfected into 0.25–
0.5 3 106 cells using the Amaxa Nucleofection kit or Bio-Rad along with thepRL-TK vector for normalization. Assays were performed 24–48 hr later using
the Dual-Glo Luciferase Assay System (Promega). The basal activity of the
empty luciferase vector was set as 1.0.
Gene Array Expression Analysis and RT-PCR Analysis
RNAwas isolated fromMEFdepletedmouse ESCs or frommechanically sepa-
rated EpiSC and EpiSC-like cells lines using the RNeasy Mini Kit (QIAGEN).
Sample processing is described in the Supplemental Experimental Proce-
dures. Heatmap and trees were visualized by Java Treeview. Microarray
data are available at the NCBI Gene Expression Omnibus database
(GSE15603). For RT-PCR analysis, 1 mg of DNase I-treated RNA was reverse
transcribed using a First Strand Synthesis kit (Invitrogen) and ultimately resus-
pended in 100 ml of water. Quantitative PCR analysis was performed in tripli-
cate using 1/50 of the reverse transcription reaction in an ABI Prism 7000
(Applied Biosystems).
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Microarray data are available at the NCBI Gene Expression Omnibus database
with accession number GSE15603.
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